# US 2024/0189370 A1 · A composition comprising Pediococcus Pentosaceus for use in treatment and/or prevention of food and/or alcohol poisoning

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189370 A1
- Document ID: US20240189370A1
- Status: Published application
- Kind: A1
- Application number: 18/555,515
- Filed: 2022-08-11
- Published: 2024-06-13
- Earliest claimed: 2021-08-31
- Inventors: Eric BEAUSSANT TÖRNE; Evaggelos SCHJÖLIN
- Web page: https://patentgrep.com/patent/US20240189370A1

## CPC

- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K 36/064: Saccharomycetales, e.g. baker's yeast
- A61P 25/32: Alcohol-abuse
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition comprising Pediococcus pentosaceus, one or more yeast, wherein a weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.5:1, and optionally one or more minerals, sugar and pharmaceutical acceptable excipients, additives and/or adjuvants. The invention also relates to a use of the composition as food supplement or in treatment and/or prevention of a disease in a mammal, such as a human and a use in treatment and/or prevention of food and/or alcohol poisoning in a mammal.

## Claims

### Claim 1

A composition comprising
0.1 to 5 wt %, at 103 to 1011 CFU/g Pediococcus pentosaceus, wherein P. pentosaceus is the sole bacterium in the composition,
1 to 50 wt % at 105 to 1015 CFU/g one or more yeast, such as any brewer's yeast or Saccharomyces cerevisiae, wherein the ratio weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.1:1,
1 to 80 wt %, or 1 to 30 wt % one or more minerals, and
optionally 1 to 40 wt % sugar, and up to 100 wt % pharmaceutical acceptable excipients, additives and/or adjuvants.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein the composition consists of
0.1 to 5 wt %, at 103 to 1011 CFU/g Pediococcus pentosaceus, wherein P. pentosaceus is the sole bacterium in the composition,
1 to 50 wt % at 105 to 1015 CFU/g one or more yeast, such as any brewer's yeast or Saccharomyces cerevisiae, wherein the ratio weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.1:1,
1 to 80 wt %, or 1 to 30 wt % one or more minerals, and
optionally 1 to 40 wt % sugar, and up to 100 wt % pharmaceutical acceptable excipients, additives and/or adjuvants.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein the composition comprises or consist of
0.1 to 2 wt %, at 105 to 109 CFU/g Pediococcus pentosaceus,
1 to 25 wt % at 107 to 1011 CFU/g one or more yeast, such as any brewer's yeast or Saccharomyces cerevisiae, wherein the ratio weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.1:1,
1 to 75 wt % one or more minerals, and
optionally 1 to 30 wt % sugar, and up to 100 wt % pharmaceutical acceptable excipients, additives and/or adjuvants.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein the weight ratio of Pediococcus pentosaceus:yeast is between 0.04 to 0.08:1.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein P. pentosaceus in an amount of 1 wt % or less at 105 to 108 CFU/g.

### Claim 6 (depends on 1)

The composition according to claim 1, wherein one or more minerals are selected from the group comprising zinc, magnesium, sodium and calcium.

### Claim 7 (depends on 1)

The composition according to claim 1, wherein the composition comprises zinc salt or zinc sulfate in an amount of 0.01 to 5 wt %, wherein weight percentages are percentages of the total composition, and optionally one or more minerals, sugar and pharmaceutical acceptable excipients, additives and/or adjuvants.

### Claim 8 (depends on 1)

The composition according to claim 1, wherein the composition comprises magnesium salt or magnesium oxide in an amount of 0.01 to 20 wt %, and optionally one or more minerals, sugar and pharmaceutical acceptable excipients, additives and/or adjuvants, wherein weight percentages are percentages of the total composition.

### Claim 9 (depends on 1)

The composition according to claim 1, wherein the composition comprises calcium salt or calcium carbonate in an amount of 0.01 to 50 wt %, and optionally sugar, pharmaceutical acceptable excipients, additives and/or adjuvants, wherein weight percentages are percentages of the total composition.

### Claim 10 (depends on 1)

The composition according to claim 1, wherein the composition comprises sodium salt or sodium chloride in an amount of 0.01 to 90 wt %, and optionally sugar, pharmaceutical acceptable excipients, additives and/or adjuvants, wherein weight percentages are percentages of the total composition.

### Claim 11 (depends on 1)

The composition according to claim 1, wherein the composition comprises
0.05 to 5 wt % or less P. pentosaceus at 105 to 108 CFU/g, and
1 to 40 wt % or 20 wt % or 10 wt % or less of one or more yeast at 105 to 1015 CFU/g, wherein the ratio weight ratio of Pediococcus pentosaceus:yeast is between 0.01 to 0.1:1,
0 to 5 wt % or 2 wt %, or 1 wt % or 0.75 wt % or less of zinc salt or zinc sulfate,
0 to 20 wt % or 15 wt % or 10 wt % or 7.5 wt % or less of magnesium salt or magnesium oxide,
0 to 50 wt % or 40 wt % or 30 wt % or 20 wt % or less of calcium salt or calcium carbonate,
0 to 90 wt % or 80 wt % or 70 wt % or 50 wt % or less of sodium salt or sodium chloride,
0 to 50 wt % or 40 wt % or 30 wt % or 20 wt % or less of sugar or dextrin, and
optionally pharmaceutical acceptable excipients, additives and/or adjuvants, wherein weight percentages are percentages of the total composition.

### Claim 12 (depends on 1)

The composition according to claim 1, wherein Pediococcus pentosaceus is selected from the group comprising P. pentosaceus CRAG3, P. pentosaceus SP2, P. pentosaceus OA1 and P. pentosaceus S3N3, P. pentosaceus SWU73571, P. pentosaceus DSM 16,244, P. pentosaceus Q6, P. pentosaceus 4012, P. pentosaceus SL001, P. pentosaceus PP8, P. pentosaceus B49, P. pentosaceus S22, P. pentosaceus ICVB491, P. pentosaceus ICVB491, P. pentosaceus LUHS183, P. pentosaceus UR1, P. pentosaceus T1, P. pentosaceus UR1, P. pentosaceus Z13P, P. pentosaceus BaltBio02, P. pentosaceus SK25, P. pentosaceus 411, P. pentosaceus MP12, P. pentosaceus TG2, P. pentosaceus No. 183, P. pentosaceus KCC-23, P. pentosaceus PPCS, P. pentosaceus HM, P. pentosaceus L006, P. pentosaceus K 23-2, P. pentosaceus LMQS 331.3, P. pentosaceus CFF4, P. pentosaceus (TC48), P. pentosaceus ST65ACC, P. pentosaceus UR1, P. pentosaceus DT016, P. pentosaceus ATCC 43,200, P. pentosaceus B49, P. pentosaceus GS4, P. pentosaceus AK-23, P. pentosaceus ON89A, P. pentosaceus KFT18, P. pentosaceus NB-17, P. pentosaceus Sn26, P. pentosaceus M41, P. pentosaceus SL4, P. pentosaceus CRAG3, P. pentosaceus FP3, P. pentosaceus S-SU6, P. pentosaceus MYU 759, P. pentosaceus AR243, P. pentosaceus DK1, P. pentosaceus LAB6, P. pentosaceus LP28, P. pentosaceus KID7, P. pentosaceus FB145, P. pentosaceus FB181, P. pentosaceus xy46, P. pentosaceus CFR R38 and R35, P. pentosaceus CFR R123, P. pentosaceus GY23, P. pentosaceus HN8, P. pentosaceus SB83, P. pentosaceus ATCC 43,200, P. pentosaceus KID7, P. pentosaceus GS4, P. pentosaceus MZF16, P. pentosaceus HUG0702, P. pentosaceus LI05, P. pentosaceus CRAG3 and P. pentosaceus HH-PP57, or mixtures thereof.

### Claim 13 (depends on 1)

The composition according to claim 1, wherein the one or more yeast is a Saccharomyces cerevisiae strain selected from the group comprising S. cerevisiae strain Kyokai no. 7 (K7), S. cerevisiae strain ATCC 204508, S. cerevisiae strain YGL118W, S. cerevisiae strain YBR134C, S. cerevisiae strain YDL102W, Saccharomyces cerevisiae var. boulardii, Saccharomyces cerevisiae var. boulardii Hansen CBS 5926, S. cerevisiae strain CNCM I-1079 and S. cerevisiae strain DBVPG6763, or mixtures thereof.

### Claim 14 (depends on 1)

The composition according to claim 1, wherein the sugar is selected from the group comprising fructose, sucrose, dextrose, acesulfame k, alitame, aspartame, dextrose, fructose, galactose, inulin, isomalt, lactitol, maltitol, maltose, mannitol, neohesperidin dihydrochalcone, saccharin, sodium cyclamate, sorbitol, sucralose, sucrose, tagatose, thaumatin, trehalose, xylitol and dextrin, or mixtures thereof.

### Claim 15 (depends on 1)

The composition according to claim 1, wherein the excipients/additives/adjuvants are selected from the group comprising cellulose, such as microcrystalline cellulose, potato fiber, rice fiber, psyllium, (poly)saccharide, glycol, propylene glycol, polyethylene glycol 400, monooleate, sorbitan monolaurate (Span 20), anionic or nonionic surfactants, anti-foaming agents, wetting agent, such as monopalmitate, sucrose dioleate, detergent, such as sorbitan monolaurate, triethanolamine oleate, PEG-8 laurate.solubilizer, such as monopalmitate (Tween 60), sodium oleate, polyoxyethylene stearate, magnesium stearate, potassium oleate, preservatives, such as sorbic acid, viscosity modifiers/suspending agents, such as cellulose derivatives (e.g., methylcellulose, microcrystalline cellulose, carboxymethylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropyl cellulose and hydroxypropyl methylcellulose etc), clays (e.g., hectorite, bentonite, aluminium and/or magnesium silicate), natural gums (e.g., acacia, guar gum, tragacanth, xanthan gum, alginates, carrageenan and locust bean gum), synthetic polymers (e.g., carbomers, polyvinyl pyrrolidone, polyvinyl alcohol and poloxamer), and miscellaneous compounds (e.g., colloidal silicon dioxide and silicates).

### Claim 16 (depends on 1)

The composition according to claim 1, wherein the excipients/additives/adjuvants are microcrystalline cellulose and magnesium stearate.

### Claim 17 (depends on 1)

The composition according to claim 1, for use in treatment and/or prevention of a disease in a mammal, such as a human.

### Claim 18 (depends on 1)

The composition according to claim 1, for use in treatment and/or prevention of food poisoning.

### Claim 19 (depends on 1)

The composition according to claim 1, for use in treatment and/or prevention of alcohol poisoning.

### Claim 20 (depends on 1)

Use of the composition according to claim 1, as a food supplement.

### Claim 21 (depends on 1)

A dosage form comprising one or two tablets or capsules comprising the composition according to claim 1, wherein the dosage form is administered at least together with the first alcohol consumption and together with the last alcohol consumption.

### Claim 22 (depends on 1)

The composition according claim 1, for use in a dosage regime, wherein the composition is administered at least together with the first alcohol consumption and together with the last alcohol consumption.

### Claim at position 23

23-28. (canceled)
